Результаты поиска

Topical ruxolitinib for chronic cutaneous graft-versus-host disease: a single-centre, randomised, double-blind, intra-patient-controlled phase 2 trial.

BACKGROUND: Oral ruxolitinib, a Janus kinase (JAK) 1/2 inhibitor, is approved for both acute and chronic graft-versus-host disease (cGVHD), whereas the topical formulation is approved for atopic dermatitis and vitiligo. Topical corticosteroids remain the mainstay for cutaneous cGVHD but their use is limited by adverse effects. We aimed to evaluate the clinical activity and safety of ruxolitinib 1·5% cream for epidermal or superficially sclerotic cutaneous cGVHD. METHODS: In this single-centre, randomised, double-blind, intra-patient-controlled phase 2 trial at Memorial Sloan Kettering Cancer …

Cutaneous Adverse Events of New Anti-melanoma Therapies: Classification and Management.

Over the past decade, targeted therapies such as BRAF inhibitors, MEK inhibitors and immunotherapies such as anti-CTLA4 and anti-PD1 antibodies have emerged as novel treatments of advanced melanoma. Along with increased use of these therapies, a range of cutaneous adverse events have also emerged, varying from more serious and frequent cutaneous squamous cell carcinoma to mere cosmetic changes such as curly hair or rare severe toxic epidermal necrolysis. Early detection and management of these cutaneous adverse events will aid patients to receive accurate treatment, avoid unnecessary discontin

Photolichenoid plaques with associated vitiliginous pigmentary changes.

A 49-year-old man with advanced HIV/AIDS on anti-retroviral therapy (HAART) and trimethoprim-sulfamethoxazole (TMP-SMX) presented with a several-month history of pruritic, erythematous, lichenified papules that coalesced into hyperkeratotic plaques on the trunk and extremities in a sun-exposed distribution. He shortly thereafter developed a progressive depigmentation over more than 80 percent of his body surface area. A biopsy specimen of an erythematous plaque on the trunk showed a superficial and mid-dermal infiltrate of lymphocytes with eosinophils, most consistent with either chronic liche

Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma.

The melanosomal protein TRP2 expressed by melanocytes and most melanoma cells is an attractive, clinically relevant model antigen for the experimental development of melanoma immunotherapy in mice. A peptide shared by murine and human TRP2 can be recognized by melanoma-reactive CTL in C57BL/6 mice, as well as in human melanoma patients. Previous experiments demonstrated that gene gun immunization of mice with plasmid DNA encoding autologous murine TRP2 was unable to induce protective immunity against B16 melanoma cells naturally expressing TRP2. In the present study, we investigated whether th

Rademikibart monotherapy for moderate-to-severe atopic dermatitis in a 1-year, randomized phase II trial (SEASIDE CHINA): initial 2-week dosing, followed by 2-week or 4-week dosing.

BACKGROUND: Rademikibart (CBP-201) is a potent, next-generation human monoclonal antibody optimized to bind with high affinity to interleuki … (TEAEs) were treatment related. Three patients discontinued rademikibart owing to TEAEs (AD flare, vitiligo, pregnancy). CONCLUSIONS: Rademikibart Q2W induced rapid improvements in AD lesions and pruritus during the initial 16 weeks, which were maintained/improved further with rademikibart Q2W or Q4W across an additional 36 weeks. Rademikibart Q2W and Q4 …

Risk of secondary autoimmune diseases with alemtuzumab treatment for multiple sclerosis: a systematic review and meta-analysis.

BACKGROUND AND PURPOSE: The objective of this study is to evaluate the risk of secondary autoimmune diseases in multiple sclerosis (MS) pati … 0 [0.0000, 0.0929] (I²=0%, p=0.57); alopecia areata (AA), 0.0159 [0.0024, 0.0372] (I²=19%, p=0.29); vitiligo, 0.0134 [0.0044, 0.0223] (I²=0%, p=0.81); inflammatory atrichia (IA), 0.0103 [0.0000, 0.0232] (I²=0%, p=0.43); chronic urticaria (CU), 0.0107 [0.0000, 0.0233] (I²=0%, p=0.60); and nephropathy, 0.0051 [0.0000, 0.0263] (I²=62%, p=0.02). CONCLUSION: T …

Nail Whispers Revealing Dermatological and Systemic Secrets: An Analysis of Nail Disorders Associated With Diverse Dermatological and Systemic Conditions.

Background and objective Nail disorders encompass a wide spectrum of conditions, spanning congenital, developmental, infectious, neoplastic, … 1%), epidermolysis bullosa (1%), racquet nail (1%), leprosy (1%), pityriasis rubra pilaris (0.67%), vitiligo (0.67%), secondary syphilis (0.67%), pachyonychia congenita (0.67%), as well as a case each of total leukonychia, subungual warts, Koenen tumor, and periungual fibroma(0.33%). Systemic autoimmune connective tissue disorders (CTD) accounted for 9%; t …

Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials.

IMPORTANCE: Alzheimer disease (AD) is a neurodegenerative disorder characterized by cognitive deterioration and impaired activities of daily … ical conditions or medication use, significant cerebrovascular pathologic findings, or a history of vitiligo and/or current evidence of postinflammatory hypopigmentation. AMARANTH screened 6871 patients; 2218 (32.3%) were randomized, and 539 patients completed the study. DAYBREAK-ALZ screened 5706 patients; 1722 (30.2%) were randomized, and 76 patients com …

BREG cells in Hashimoto's thyroiditis isolated or associated to further organ-specific autoimmune diseases.

Hashimoto thyroiditis (HT) may occur isolated or associated with other non-endocrine autoimmune disorders (NEAD). No data are available about Breg cells in these disorders and this represented the aim of the study. Th17 and Breg cells subset were characterized on peripheral blood mononuclear cells isolated from 18 healthy donors (HD), 19 patients with isolated HT and 26 patients with HT+NEAD. Th17 were higher in patients with isolated HT than in HD but no further changes were seen in patients with HT+NEAD. CD24hiCD38hi unstimulated Breg cells were similar in HT patients and in HD, but signific

Helper T-cell responses and clinical activity of a melanoma vaccine with multiple peptides from MAGE and melanocytic differentiation antigens.

PURPOSE: A phase I/II trial was performed to evaluate the safety and immunogenicity of a novel melanoma vaccine comprising six melanoma-associated peptides defined as antigenic targets for melanoma-reactive helper T cells. Source proteins for these peptides include MAGE proteins, MART-1/MelanA, gp100, and tyrosinase. PATIENTS AND METHODS: Thirty-nine patients with stage IIIB to IV melanoma were vaccinated with this six-peptide mixture weekly at three dose levels, with a preceding phase I dose escalation and subsequent random assignment among the dose levels. Helper T-lymphocyte responses were

Схематическая оценка недостаточности витамина D в связи с аутоиммунными расстройствами и их последствий для внутренней медицины.

Иммунная система в значительной степени зависит от витамина D в том, что касается ее функции, несмотря на тот факт, что дефицит этого питательных веществ в настоящее время широко признается в качестве фактора, способствующего развитию нескольких аутоиммунных расстройств. В ходе этого исследования было установлено наличие дефицита витамина D у пациентов, страдающих аутоиммунной болезнью, и были исследованы его последствия для внутренней медицины. Два медицинских следователя искали в нескольких электронных базах данных, таких, как PubMed, Scopus, Web of Science и Google Scientific, для проведени

Совпадение в полном тексте источника
… Mahmmod and Ismael et al., 2022 (Iraq) [ 20 ] 46 Cross-sectional Vitiligo Most vitiligo patients had low vitamin D levels (p<0.05), mostly females (p=0.642), with no significant effect on VETI scores (p=0.184). … The majority of vitiligo patients had low vitamin D levels, with higher deficiency observed in females. …

Аутоиммунные заболевания связаны с повышенным нейродегенеративным и цереброваскулярным риском, в то время как системное кортикостероидное воздействие свидетельствует об ограниченной нейродегенеративной и скромной сосудистой связи.

Системные аутоиммунные заболевания (СИД), характеризующиеся хроническим периферийным воспалением и частой сосудистой коморбидностью, все чаще связаны с неблагоприятными результатами центральной нервной системы (СНС); однако сравнительные данные по различным АИД и разъяснения роли сосудистого бремени, провокационной деятельности и иммуномодуляционной терапии по-прежнему ограничены. Используя Глобальную сеть сотрудничества TriNetX, мы провели ряд ретроспективных экспериментов, совпадающих с оценками, для взрослых в возрасте от 50 до 85 лет в целях количественной оценки заболевания Паркинсона (PD

Совпадение в полном тексте источника
… Conditions with the largest female excess included, for TIA, Addison’s disease (F/M 1.52, 1.34–1.73), vitiligo (1.49, 1.29–1.72), and ulcerative colitis (1.42, 1.28–1.58), and for ischemic stroke, vitiligo (1.40, 1.28–1.54), Graves’ disease (1.35, 1.29–1.41), and Sjögren syndrome (1.32, 1.26–1.38). … Vitiligo (tacrolimus): male ischemic stroke was lower in treated cohorts (p = 0.040); other outcomes were null. …

New Approach to Addison Disease: Oral Manifestations Due to Endocrine Dysfunction and Comorbidity Burden.

This review highlights oral anomalies with major clinical impact in Addison disease (AD), including dental health and dermatologic features, … angular cheilitis, buccal petechial lesions, and PD). In more than half of the patients, associated vitiligo involves depigmentation of oral mucosa at different levels (palatal, gingival, alveolar, buccal mucosa, and lips). Celiac disease may manifest xerostomia, dry lips, OU, sialadenitis, recurrent aphthous stomatitis and dental enamel defects in childre …

Diabetes mellitus and the skin.

Several dermatoses are routinely associated with diabetes mellitus, especially in patients with chronic disease. This relationship can be easily proven in some skin disorders, but it is not so clear in others. Dermatoses such necrobiosis lipoidica, granuloma annulare, acanthosis nigricans and others are discussed in this text, with an emphasis on proven link with the diabetes or not, disease identification and treatment strategy used to control those dermatoses and diabetes.

Совпадение в полном тексте источника
… can be considered, as the treatment of vitiligo is unsatisfactory in general. … Why vitiligo in diabetes. Egypt Dermatol Online J. 2005;1:8–8. 101. Huang CL, Nordlund JJ, Boissy R. Vitiligo: a manifestation of apoptosis? Am J Clin Dermatol. 2002;3:301–308. doi: 10.2165/00128071-200203050-00001. 102. Dittmar M, Kahaly GJ. …

Premature hair graying: a multifaceted phenomenon.

Premature hair graying (PHG) is the early loss of natural hair color, influenced by genetic, biological, and environmental factors. This review discusses the significant psychological impacts of PHG and explores its underlying mechanisms, related health conditions, and available treatments. The review examines the roles of genetics, oxidative stress, and lifestyle factors such as smoking and diet in premature graying. It also considers associated medical conditions and current and emerging treatment options. This overview aims to improve understanding of PHG and its broader implications.

Совпадение в полном тексте источника
… Among autoimmune conditions, vitiligo contributes significantly to premature graying. … , 41 Beyond vitiligo, autoimmune conditions such as hypothyroidism also play a role in PHG. …

Novel melanoma therapies and their side effects.

In the last few years, melanoma treatment has been revolutionized by the development of immune checkpoint-blocking antibodies or immune checkpoint inhibitors including ipilimumab, vemurafenib, dabrafenib, trametinib, nivolumab, and pembrolizumab. Although they have shown promising results, they also have caused multiple adverse events (AEs), particularly immune-related AEs (irAEs). Specialists should be familiar with these AEs.

Cutaneous manifestations of systemic diseases.

Many aspects of dermatologic diagnosis are either of importance or interest to the nondermatologist, and there are many excellent textbooks available for guidance. This article focuses on four categories of conditions that are the source of frequent queries from the primary care setting: (1) common skin diseases that frequently mimic systemic illness, (2) common skin diseases that have important systemic associations, (3) common systemic diseases that have prominent cutaneous findings, and (4) the seldom seen but frequently raised concerns regarding cutaneous signs of internal malignancy.